ECAT | RORO | ECAT / RORO | |
Gain YTD | 13.789 | -4.967 | -278% |
Net Assets | 1.64B | 3.91M | 41,816% |
Total Expense Ratio | 1.30 | 1.14 | 114% |
Turnover | 227.00 | 1855.00 | 12% |
Yield | 2.18 | 4.03 | 54% |
Fund Existence | 4 years | 5 years | - |
ECAT | RORO | |
---|---|---|
RSI ODDS (%) | 3 days ago82% | 3 days ago83% |
Stochastic ODDS (%) | 3 days ago76% | 3 days ago78% |
Momentum ODDS (%) | 3 days ago85% | 3 days ago80% |
MACD ODDS (%) | 3 days ago88% | 3 days ago85% |
TrendWeek ODDS (%) | 3 days ago78% | 3 days ago84% |
TrendMonth ODDS (%) | 3 days ago87% | 3 days ago73% |
Advances ODDS (%) | 3 days ago86% | 7 days ago77% |
Declines ODDS (%) | 7 days ago81% | N/A |
BollingerBands ODDS (%) | 3 days ago72% | 3 days ago86% |
Aroon ODDS (%) | 3 days ago90% | 3 days ago66% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LAMSX | 24.21 | -0.01 | -0.04% |
Lord Abbett Dividend Growth R4 | |||
CLBEX | 36.77 | -0.03 | -0.08% |
American Funds American Balanced 529E | |||
NSOIX | 17.18 | -0.03 | -0.17% |
North Star Opportunity I | |||
RYVLX | 616.72 | -1.20 | -0.19% |
Rydex NASDAQ-100® 2x Strategy A | |||
NNLEX | 25.30 | -0.21 | -0.82% |
Nicholas Limited Edition N |